Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.4200 (0.95%) ($16.4200 - $16.4200) on Thu. Jun. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.46% (three month average) | RSI | 83 | Latest Price | $16.4200(0.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.73% in a week (0% probabilities). VIXM(-23%) UUP(-14%) VXX(-7%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.73% (StdDev 5.46%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $15.83(3.73%) | 10 Day Moving Average | $14.81(10.87%) | 20 Day Moving Average | $13.95(17.71%) | To recent high | 0% | To recent low | 72.9% | Market Cap | $2.897b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |